BD Biosciences, a segment of BD (Becton, Dickinson and Company), has launched the BD Kaleidoscope reagent and dye expansion program—marked by the release of nearly 200 new fluorochrome-conjugated antibodies for flow cytometry to help meet today’s life science research needs.
Multicolor flow cytometry allows researchers to analyze multiple parameters simultaneously, enhancing discovery and problem solving by providing them with a wealth of information in a single experiment.
The BD Kaleidoscope portfolio offers these new fluorochrome-conjugated antibodies in a full range of colors, making it easier to construct multicolor cocktails to obtain fluorescently separated cell populations more efficiently. In addition, researchers can choose from a wide range of sizes, such as the new 50 test/50 mg size to reduce the cost of initial panel design and testing. The new BD reagents, like others in the BD Biosciences portfolio, are optimized for use with BD flow cytometry systems.
This product was featured in Drug Discovery & Development magazine: Vol. 12, No. 10, November/December 2009, p. 10.